43742-1454 NDC - MATRIX SUPPORT (CEANOTHUS AMERICANUS, VERATRUM ALBUM, ANACARDIUM ORIENTALE, ARGENTUM NITRICUM, CONDURANGO, HYDRASTIS CANADENSIS, MOMORDICA BALSAMINA, OXALIS ACETOSELLA, PULSATILLA (VULGARIS), BILE DUCT (SUIS), COLON (SUIS), DUODENUM (SUIS), ESOPHAGUS (SUIS), EYE (SUIS), GALLBLADDER (SUIS), ILEUM (SUIS), INTESTINE (SUIS), IPECACUANHA, JEJUNUM (SUIS), KALI BICHROMICUM, LUNG (SUIS), MUCOSA NASALIS SUIS, NATRUM OXALACETICUM, ORAL MUCOSA (SUIS), PHOSPHORUS, RECTAL MUCOSA (SUIS), STOMACH (SUIS), SULPHUR, MANNAN,)

Drug Information

Product NDC: 43742-1454

Proprietary Name: Matrix Support

Non Proprietary Name: Ceanothus Americanus, Veratrum Album, Anacardium Orientale, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Oxalis Acetosella, Pulsatilla (Vulgaris), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Mannan,

Active Ingredient(s):
  • 4 [hp_X]/mL CEANOTHUS AMERICANUS LEAF;
  • 6 [hp_X]/mL GOLDENSEAL;
  • 8 [hp_X]/mL IPECAC;
  • 10 [hp_X]/mL LACHESIS MUTA VENOM;
  • 10 [hp_X]/mL MANDRAGORA OFFICINARUM ROOT;
  • 6 [hp_X]/mL MARSDENIA CONDURANGO BARK;
  • 6 [hp_X]/mL MOMORDICA BALSAMINA IMMATURE FRUIT;
  • 6 [hp_X]/mL OXALIS ACETOSELLA LEAF;
  • 8 [hp_X]/mL PHOSPHORUS;
  • 8 [hp_X]/mL PORK INTESTINE;
  • 8 [hp_X]/mL POTASSIUM DICHROMATE;
  • 6 [hp_X]/mL PULSATILLA VULGARIS;
  • 6 [hp_X]/mL SEMECARPUS ANACARDIUM JUICE;
  • 30 [hp_C]/mL SHIGELLA DYSENTERIAE;
  • 6 [hp_X]/mL SILVER NITRATE;
  • 8 [hp_X]/mL SODIUM DIETHYL OXALACETATE;
  • 8 [hp_X]/mL SULFUR;
  • 8 [hp_X]/mL SUS SCROFA BILE DUCT;
  • 8 [hp_X]/mL SUS SCROFA COLON;
  • 8 [hp_X]/mL SUS SCROFA DUODENUM;
  • 8 [hp_X]/mL SUS SCROFA ESOPHAGUS;
  • 8 [hp_X]/mL SUS SCROFA EYE;
  • 8 [hp_X]/mL SUS SCROFA GALLBLADDER;
  • 8 [hp_X]/mL SUS SCROFA ILEUM;
  • 8 [hp_X]/mL SUS SCROFA JEJUNUM;
  • 8 [hp_X]/mL SUS SCROFA LUNG;
  • 8 [hp_X]/mL SUS SCROFA NASAL MUCOSA;
  • 8 [hp_X]/mL SUS SCROFA ORAL MUCOSA;
  • 8 [hp_X]/mL SUS SCROFA RECTAL MUCOSA;
  • 8 [hp_X]/mL SUS SCROFA STOMACH;
  • 6 [hp_C]/mL SUS SCROFA URINARY BLADDER;
  • 8 [hp_X]/mL VERATRUM ALBUM ROOT;
  • 10 [hp_X]/mL WOOD CREOSOTE;
  • 8 [hp_X]/mL YEAST MANNAN


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Labeler Information

Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:4/1/2019
End Marketing Date:4/8/2024

Package Information

No. Package Code Package Description Billing Unit
143742-1454-130 mL in 1 BOTTLE, DROPPER (43742-1454-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-1454The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEMatrix SupportThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECeanothus Americanus, Veratrum Album, Anacardium Orientale, Argentum Nitricum, Condurango, Hydrastis Canadensis, Momordica Balsamina, Oxalis Acetosella, Pulsatilla (Vulgaris), Bile Duct (Suis), Colon (Suis), Duodenum (Suis), Esophagus (Suis), Eye (Suis), Gallbladder (Suis), Ileum (Suis), Intestine (Suis), Ipecacuanha, Jejunum (Suis), Kali Bichromicum, Lung (Suis), Mucosa Nasalis Suis, Natrum Oxalaceticum, Oral Mucosa (Suis), Phosphorus, Rectal Mucosa (Suis), Stomach (Suis), Sulphur, Mannan,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/1/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE4/8/2024This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECEANOTHUS AMERICANUS LEAF; GOLDENSEAL; IPECAC; LACHESIS MUTA VENOM; MANDRAGORA OFFICINARUM ROOT; MARSDENIA CONDURANGO BARK; MOMORDICA BALSAMINA IMMATURE FRUIT; OXALIS ACETOSELLA LEAF; PHOSPHORUS; PORK INTESTINE; POTASSIUM DICHROMATE; PULSATILLA VULGARIS; SEMECARPUS ANACARDIUM JUICE; SHIGELLA DYSENTERIAE; SILVER NITRATE; SODIUM DIETHYL OXALACETATE; SULFUR; SUS SCROFA BILE DUCT; SUS SCROFA COLON; SUS SCROFA DUODENUM; SUS SCROFA ESOPHAGUS; SUS SCROFA EYE; SUS SCROFA GALLBLADDER; SUS SCROFA ILEUM; SUS SCROFA JEJUNUM; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; SUS SCROFA ORAL MUCOSA; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; VERATRUM ALBUM ROOT; WOOD CREOSOTE; YEAST MANNANAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH4; 6; 8; 10; 10; 6; 6; 6; 8; 8; 8; 6; 6; 30; 6; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 6; 8; 10; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023